Company news
vTv Therapeutics Inc. news in 2022
vTv Therapeutics Inc.'s news releases, calls and decks from 2022, newest first.
vTv Therapeutics Appoints Biotech Industry Veteran Steven Tuch as Chief Financial Officer
December 12, 2022
vTv Therapeutics Announces 2022 Third Quarter Financial Results and Provides Corporate Update
November 9, 2022
vTv Therapeutics Announces 2022 Second Quarter Financial Results and Provides Corporate Update
August 14, 2022
vTv Therapeutics Announces Paul Sekhri as new President and Chief Executive Officer
July 26, 2022
vTv Therapeutics Announces Investment by CinRx Pharma
July 24, 2022
vTv Therapeutics Announces Publication in Diabetes Obesity and Metabolism of Complete Results for the Mechanistic Study Assessing Effects of TTP399 on Ketones during Acute Insulin Withdrawal in Patients with Type 1 Diabetes
June 3, 2022
vTv Therapeutics Announces Investment by and Entry into Collaboration and License Agreement with affiliates of G42 Healthcare
May 31, 2022
vTv Therapeutics Announces 2022 First Quarter Financial Results and Provides Corporate Update
May 11, 2022
vTv Therapeutics Announces 2021 fourth Quarter and Full Year Financial Results and Provides Corporate Update
March 28, 2022
vTv Therapeutics Announces CEO Transition
March 2, 2022
vTv Therapeutics Shares Updated Corporate Presentation
January 12, 2022